Mk-677 ibutamoren

Mechanism of action

Agonism of the GHS-R1a receptor (ghrelin receptor) at the hypothalamic-pituitary level → increased pulsatile GH secretion → increased hepatic and peripheral IGF-1. Secondary effects consistent with the ghrelin/GH axis: increased appetite (orexigenic), possible fluid retention (via GH/IGF-1), sleep modulation (increased slow-wave sleep in some studies), and potential alterations in insulin sensitivity and blood glucose (likely reduced insulin sensitivity in some individuals).

Supported benefits

• Consistent increase in circulating GH and IGF-1 (strong)
• Increase in lean body mass in some studies in older adults/frailty; not always accompanied by a proportional increase in strength (moderate)
• Possible improvement in some sleep parameters (e.g. increased slow-wave sleep) in specific populations (limited)
• Possible support for markers of bone turnover and potential impact on bone mineral density with prolonged use (evidence not conclusive) (emerging)

Safety & side effects

• Increased appetite (frequent)
• Fluid retention/peripheral edema, weight gain due to fluids
• Paresthesia or carpal tunnel-like symptoms (reported with stimulation of the GH/IGF-1 axis in some individuals)
• Lethargy or drowsiness in some cases
• Increased fasting blood glucose and/or reduced insulin sensitivity; possible worsening of glycemic control
• Possible increase in blood pressure in predisposed individuals (often mediated by fluid retention)
• Joint or muscle pain (less common, but reported)

FAQ

Is MK-677 really a peptide?

No. It is often placed in the “peptides” category in fitness language, but chemically it is a small non-peptide molecule. The effect is similar to that of GH secretagogues because it activates the ghrelin receptor (GHS-R1a).

Does increasing GH and IGF-1 automatically mean more strength and performance?

Not necessarily. Studies show increases in GH/IGF-1 and sometimes lean mass, but the transfer to strength, power, and sport-specific performance is not guaranteed and depends on training, diet, sleep, and the individual risk profile.

Why can it increase blood glucose?

Stimulation of the GH/IGF-1 axis can reduce insulin sensitivity in some individuals, increasing blood glucose and insulin. This is a critical safety issue, especially in those predisposed to diabetes or metabolic syndrome.

Is it detectable in anti-doping tests?

Yes. It is considered a prohibited substance, and anti-doping laboratories can detect many substances and/or metabolites; moreover, unregulated products may contain additional doping compounds.

Are the effects on sleep certain?

There are data suggesting improvements in some sleep parameters (e.g. slow-wave sleep) in specific populations, but the evidence is not uniform and the effects can vary greatly between individuals.